Howard Njoo

The federal government announced plans on Thursday, July 14, 2022, to start randomly testing travellers at Canada's four main airports for COVID-19 again next week, but intends to move the actual swabbing off-site.

Canada's drug regulator approved Moderna's COVID-19 vaccine for infants and preschoolers on Thursday, July 14, 2022, making it the first vaccine approved for that age group in the country.

Quebec will be the first Canadian province to launch a vaccination campaign against the monkeypox virus, interim public health director Dr. Luc Boileau said Thursday, adding that 25 cases of the disease have been confirmed in the Montreal area.

The news conference at the beginning of 2020 wasn’t all that different from the many Dr. Howard Njoo had held in the past.

Known as Covifenz, the vaccine was developed by Medicago, a biotechnology company based in Quebec City that uses a plant host to make virus−like particles which help the body’s immune system make antibodies.  

The federal government on Wednesday, December 15, 2021, advised Canadians against non-essential international travel in an effort to protect against the Omicron variant, while Ontario and Quebec announced thousands of new COVID-19 infections.

COVID-19 is unlikely to be wiped out completely, but it might be tamed, Canada's chief public health officer said on Monday, December 13, 2021.

Test requirements for travellers vaccinated against COVID-19 at the Canadian border need to be re-examined, particularly for short trips, says the country's top doctor.

Canada's chief public health officer is confident people will be able to cast ballots safely in an expected federal election, despite a fourth wave of COVID-19 fuelled by the highly contagious Delta variant.

The U.S. Centers for Disease Control and Prevention says people fully vaccinated against COVID-19 no longer need to wear masks outdoors and in most indoor settings, but one of Canada's top public health officials suggests a different approach would be taken here.

Canadian provinces suspended use of the Oxford-AstraZeneca COVID-19 vaccine in people under age 55 on Monday, March 29, 2021, acting on an advisory committee's concerns about a possible link between the shot and rare blood clots.

The federal government is expecting around 1.5 million doses of the Oxford-AstraZeneca vaccine from the United States today, March 30, 2021.

Canada's procurement minister says a deal is close to receive Oxford-AstraZeneca vaccine doses from the U.S., while the military commander in charge of the rollout here says all adults who wish could be able to get their first shot by July 1.

The addition of another COVID-19 vaccine to Canada's arsenal and accelerated deliveries for another had government officials taking an optimistic tone Friday about the path of the pandemic in Canada. 

There is compelling evidence that a single dose of COVID-19 vaccines may provide almost as much protection as giving two doses, Canada's deputy chief public health officer said on Thursday, February 18, 2021.